Cannabis Weekly Round-Up: Peru on Path for Legal Medical Cannabis
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Your trusted source for investing success
Your trusted source for investing success
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
InspireMD announced it has signed an agreement with Medicinália Cormédica MC Medical Lda, a medical distributor in Portugal, to distribute CGuard EPS.
By Shelly Kumar
The Hydropothecary Corporation (“THCX” or the “Company”) (TSXV:THCX) is pleased to announce its processed medical marijuana products have been granted kosher certification by the Ottawa Vaad HaKashrut. It is the only kosher certification currently granted to cannabis products in Canada.
The kosher certification, includes Decarb, the ready-to-consume activated marijuana powder product
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
The medical device industry is robust and diverse. Here are four small medical device companies that investors should watch.
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
This past trading in the cannabis marketplace saw another major dip to the Marijuana Life Sciences Index, the first medical marijuana study funded by a US medical government research group.
MediXall Group announced its MediXaid Provider Network expanded to over 3,000 healthcare providers registered for the early adopter program.
Cogentix Medical, Molecular Templates, Celldex Therapeutics, Cerus and Kura Oncology top the NASDAQ biotech stock list.
Life Science Investing News profiles five small-cap ETFs in the biotech market.
Utah Medical Products announced its board of directors approved the quarterly cash dividend of $.265 per share set to be paid on October.
Utah Medical Products shared their financial report for the second quarter of 2017.
Novavax, Agenus, Sierra Oncology, Durect and Cogentix top the NASDAQ biotech stock list.
Medigus announced a distribution agreement with Izasa Hospital, distributor of medical products in the hospital sector in Spain.
The company will be able to sell psychoactive cannabis for non-medical use in pharmacies beginning July 19.
MEI Pharma, AVEO Pharmaceuticals, Albireo Pharma, Athersys and CASI Pharmaceuticals top the list.
AVEO, leads the list of last week’s life science gainers on the NASDAQ, followed by BioDelivery Sciences, Dynavax, Catalyst and Ekso Bionics.
